Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy
about
Melatonin effects on hard tissues: bone and toothMT1 and MT2 Melatonin Receptors: A Therapeutic PerspectiveMelatonin: A Review of Its Potential Functions and Effects on Dental DiseasesThe inhibition of apoptosis by melatonin in VSC4.1 motoneurons exposed to oxidative stress, glutamate excitotoxicity, or TNF-alpha toxicity involves membrane melatonin receptors.Methylselenocysteine resets the rhythmic expression of circadian and growth-regulatory genes disrupted by nitrosomethylurea in vivoMelatonin promotes osteoblast differentiation by regulating Osterix protein stability and expression.Melatonin Potentiates the Neuroprotective Properties of Resveratrol Against Beta-Amyloid-Induced Neurodegeneration by Modulating AMP-Activated Protein Kinase Pathways.Scientific basis for the potential use of melatonin in bone diseases: osteoporosis and adolescent idiopathic scoliosis.Melatonin combats molecular terrorism at the mitochondrial level.Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives.Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night.Effect of Melatonin on the Extracellular-Regulated Kinase Signal Pathway Activation and Human Osteoblastic Cell Line hFOB 1.19 Proliferation.All-trans-retinoic acid ameliorated high fat diet-induced atherosclerosis in rabbits by inhibiting platelet activation and inflammation.5-Meth-oxy-1-[(5-meth-oxy-1H-indol-2-yl)meth-yl]-1H-indoleThe pattern of melatonin receptor expression in the brain may influence antidepressant treatmentMelatonin and oral cavityMelatonin: bone metabolism in oral cavity.Melatonin and human skin aging.Peripheral reproductive organ health and melatonin: ready for prime time.Update on the role of melatonin in the prevention of cancer tumorigenesis and in the management of cancer correlates, such as sleep-wake and mood disturbances: review and remarks.Urinary 6-sulphatoxymelatonin levels in patients with senile cataracts.Urinary 6-sulfatoxymelatonin level in age-related macular degeneration patients.Melatonin-micronutrients Osteopenia Treatment Study (MOTS): a translational study assessing melatonin, strontium (citrate), vitamin D3 and vitamin K2 (MK7) on bone density, bone marker turnover and health related quality of life in postmenopausal osBeneficial effects of melatonin in cardiovascular disease.Hepatoprotective actions of melatonin: possible mediation by melatonin receptorsMelatonin has membrane receptor-independent hypnotic action on neurons: an hypothesis.Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling.Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation.Melatonin effects on bone: potential use for the prevention and treatment for osteopenia, osteoporosis, and periodontal disease and for use in bone-grafting procedures.2',3'-Cyclic nucleotide 3'-phosphodiesterase as a messenger of protection of the mitochondrial function during melatonin treatment in aging.Melatonin: A pleiotropic molecule that modulates DNA damage response and repair pathways.Melatonin inhibits MPP+-induced caspase-mediated death pathway and DNA fragmentation factor-45 cleavage in SK-N-SH cultured cells.Melatonin inhibits fatty acid-induced triglyceride accumulation in ROS17/2.8 cells: implications for osteoblast differentiation and osteoporosis.Melatonin signaling in mouse cerebellar granule cells with variable native MT1 and MT2 melatonin receptors.New spectrofluorimetric methods for determination of melatonin in the presence of N-{2-[1-({3-[2-(acetylamino)ethyl]-5-methoxy-1H-indol-2-yl}methyl)-5-methoxy-1H-indol-3-yl]- ethyl}acetamide: a contaminant in commercial melatonin preparations.A novel calcium aluminate-melatonin scaffold enhances bone regeneration within a calvarial defect.Acute allograft rejection and immunosuppression: influence on endogenous melatonin secretion.Effects on bone by the light/dark cycle and chronic treatment with melatonin and/or hormone replacement therapy in intact female mice.The potential therapeutic effect of melatonin on human ovarian cancer by inhibition of invasion and migration of cancer stem cells.Diabetic Status Influences the Storage of Melatonin in Human Salivary Glands.
P2860
Q27026104-772337AD-A250-41AA-BC40-23FC60FE92CAQ28083929-37E9F8A3-F269-45A5-A9A4-37D58735865BQ33624917-BCB135F1-B351-41FC-8982-65014ED304E4Q33823742-99E210B0-EF6A-447E-AB69-866C8BC896F1Q33833560-1E3F748F-2BBC-4153-960F-1EFC9036836AQ33915967-32BAB145-4F9D-4949-B624-29B7FF331C31Q34180157-569E1952-56EE-4C9B-AB90-CEBEB1E6DBB0Q34211436-D06A8659-D71C-4268-9F0B-EAD04F69E36AQ34359618-7768DC1B-7365-4D18-A0C0-2519374A8BFAQ34994700-ADBA4C4A-3661-4559-8395-5C02F24B39FBQ35181910-05918551-9DF5-4D59-A33C-7303AAA0E639Q35723300-071B95B3-C3B5-4081-A1C0-5F9F0326C1E4Q35830449-5D8343ED-636D-4D61-B26B-DA8B730146A6Q35933088-AEE821E2-B759-4020-B968-17EC6300CA7DQ35945875-BEF7118D-7F9A-4717-98A4-0EC21ECC0F2EQ36076041-D201783A-9764-4D69-B9CA-5883A8CE2B4EQ36178389-3113EA6B-2932-4BA9-AFA4-6829439CF8E6Q36643569-7D313BF2-233A-4F6F-84B0-3DF317CD05EDQ36820433-45C98561-C81B-4D1F-9B89-2889FB485045Q37210222-05DE21D0-C172-4E26-A69E-D184730EB136Q37308360-F509913D-38DE-4D3F-ADBA-99538DDBE519Q37315390-EE6E5284-4C79-4189-9671-1CDE96D9747BQ37643521-C9F95C9E-1A3D-429C-8050-DA43BE087F5FQ37747491-368590E7-C318-4C83-92DE-1DA0F4017184Q37823548-548D78EA-631D-4CE5-BED6-032492E85D48Q37826442-68728066-8833-432D-9122-FB1FBCE8DA0EQ37950409-5F789BB6-268C-4208-9F14-3230A38E3D89Q38002452-0AFA93CE-D56D-4F8C-9AC1-86AE497FE13FQ38174174-41081157-304F-442C-B2E5-857C3CA2CE46Q39194311-EC8D036A-3D70-404E-9683-2E4D2DCDDB34Q39260655-8B9DF428-BC1A-4E92-BF52-559F3AEA5F67Q40103666-41EAEDCB-942E-4CA7-A905-BF5B55A683DEQ40155371-A5DBFCF5-0895-4F07-9FFD-CC4BB145C2FEQ41952507-08A15D85-D978-4938-974E-E3B9818D86B0Q42106935-E8D969B3-72E9-41BC-8BAA-02B926ABEA92Q42796352-0FB8D7E4-AF40-4449-BE9F-1EDAB790CDBAQ46703454-91842F0D-F4DA-4B43-91E3-FA9D8B74F01FQ46976099-D187B71D-A0DC-4E05-A2B9-F10542BF24BFQ47103306-8AC5DDFA-9EA8-46B1-9B36-9040C8C7AA25Q47317825-B3E0D3A8-6646-4D6A-BF0D-87FA6DC78056
P2860
Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Therapeutic treatments potenti ...... cer and as an adjuvant therapy
@ast
Therapeutic treatments potenti ...... cer and as an adjuvant therapy
@en
Therapeutic treatments potenti ...... cer and as an adjuvant therapy
@nl
type
label
Therapeutic treatments potenti ...... cer and as an adjuvant therapy
@ast
Therapeutic treatments potenti ...... cer and as an adjuvant therapy
@en
Therapeutic treatments potenti ...... cer and as an adjuvant therapy
@nl
prefLabel
Therapeutic treatments potenti ...... cer and as an adjuvant therapy
@ast
Therapeutic treatments potenti ...... cer and as an adjuvant therapy
@en
Therapeutic treatments potenti ...... cer and as an adjuvant therapy
@nl
P2093
P2860
P1476
Therapeutic treatments potenti ...... cer and as an adjuvant therapy
@en
P2093
John S Doctor
Nicholas M Radio
Vicki L Davis
P2860
P304
P356
10.1111/J.1600-079X.2006.00369.X
P407
P577
2006-11-01T00:00:00Z